RecruitingNot ApplicableNCT04783441

Use of CGM in Kidney Transplant Recipients

Continuous Glucose Monitoring (CGM) to Improve Glycemic Control in Kidney Transplant Recipients


Sponsor

University of California, Davis

Enrollment

80 participants

Start Date

Jun 29, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

The investigators want to study the impact CGM (continuous glucose monitoring) has on patients glycemic control as determined by time in range (TIR 70-180 mg/dL) in the Diabetic Kidney Transplant population.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether continuous glucose monitoring (CGM) — a wearable sensor that tracks blood sugar around the clock — helps manage blood sugar better in people who have had a kidney transplant and have Type 2 diabetes requiring insulin. Tight blood sugar control is especially important after transplant. **You may be eligible if...** - You are 18 or older and received a kidney transplant within the past year - Your transplanted kidney is working (eGFR above 30 mL/min) - You have Type 2 diabetes and are currently using insulin - You have home Wi-Fi access **You may NOT be eligible if...** - You have Type 1 diabetes - You take hydroxyurea (a medication that interferes with the CGM sensor) - You are pregnant, planning to become pregnant, or breastfeeding - You have unstable heart disease or are undergoing active cancer treatment - You are unable to check your blood sugar with a fingerstick 4 times a day when required Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEDexcom G6

access to continuous glucose monitoring in the Dexcom G6 arm 24/7

DEVICEDexcom G6 blinded sensor

retrospective access to continuous glucose profile after 10 days of wear


Locations(1)

UC Davis Health

Sacramento, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04783441


Related Trials